News

Venture Capitalists Turn to Science in Search for Next Great Investment

THE PEW CHARITABLE TRUSTS / KARA COLEMAN (NOVEMBER 21, 2019) — Although Silicon Valley is often considered the birthplace of modern entrepreneurial leadership and ideas, scientists across the country are getting attention for groundbreaking work. Investment in health research and development grew 27 percent from 2013 to 2017, for example, and several members of the Pew biomedical … Continued

Read More

Vicious circles: Ring-shaped DNA provides cancer cells with a malignant twist

Science Daily/University of California – San Diego (November 20, 2019) — Deoxyribonucleic acid or DNA encodes information, not only in its sequence but also in its shape. Building upon previous revelatory work, a team of scientists, led by researchers at University of California San Diego, the UC San Diego branch of the Ludwig Institute for … Continued

Read More

Young Investigators Named Winners of 2019 Paul Marks Prize for Cancer Research

MEMORIAL SLOAN KETTERING CANCER CENTER (New York, NY), November 12, 2019 – Memorial Sloan Kettering (MSK) has named three investigators as the recipients of this year’s Paul Marks Prize for Cancer Research. The award recognizes promising scientists for their accomplishments in the area of cancer research. The winners for 2019 are Nathanael Gray, PhD, of the Dana-Farber … Continued

Read More

Exploration of Pregnancy-Related Changes in Breast Tissue

ONCOLOGY TIMES – A century-old medical understanding recognizes the fact that a full-term pregnancy early in a woman’s life dramatically decreases her risk of breast cancer. Camila dos Santos, PhD, Assistant Professor at the Cancer Center of Cold Spring Harbor Laboratory, wants to know more about that phenomenon. She has set about interrogating breast tissue—both … Continued

Read More

The Tisch Cancer Institute and Precision Immunology Institute at Mount Sinai Launch Center for Computational Immunology

Newswise — (New York, NY – May 9, 2019) — The Tisch Cancer Institute and the Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai have launched the Center for Computational Immunology, a hub that will help researchers studying cancer, genomics, machine learning, and immunology collaborate to find better targeted immunotherapies for patients. Benjamin … Continued

Read More

President Bruce Stillman wins prestigious Gairdner Award

Cold Spring Harbor, NY — Dr. Bruce Stillman, President and CEO of Cold Spring Harbor Laboratory (CSHL), has been awarded the 2019 Canada Gairdner International Award in honor of his pivotal contributions to basic research. The Canada Gairdner International Award recognizes researchers who have made seminal discoveries or contributions to biomedical science. Dr. Stillman is being honored for “pioneering … Continued

Read More

Study identifies link between DNA-protein binding, cancer onset

Researchers at the Stanford University School of Medicine and their collaborators at other institutions have identified a link between how proteins bind to our DNA and how cancer develops. This finding may allow researchers to predict cancer pathways and long-term patient outcomes. The research focuses on chromatin, the DNA-protein complex where all genes reside. Specifically, it evaluates chromatin’s … Continued

Read More

New mRNA Cancer Drivers Revealed in Chronic Lymphocytic Leukemia

NEW YORK (GenomeWeb) – New evidence has emerged today showing that the inactivation or alteration of cancer suppressor genes can take place even if DNA itself remains unaltered. Reporting in Nature, investigators demonstrated that changes in mRNA due to a process called intronic polyadenylation (IPA) can drive development of some cancers by altering gene expression in … Continued

Read More

Researchers identify way to grow immune cells at large scale for preventing cancer reoccurrence

For the first time, Mount Sinai researchers have identified a way to make large numbers of immune cells that can help prevent cancer reoccurrence, according to a study published in August in Cell Reports. The researchers discovered a way to grow the immune cells, called dendritic cells, at large scale in the lab to study them … Continued

Read More

‘Hijacked’ cell response to stress reveals promising drug targets for blood cancer

A signaling pathway that helps promote normal cell growth worsens a form of leukemia by taking control of another pathway better known for protecting cells from biological stress, a new study shows. The discovery that the NOTCH1 pathway takes control of heat shock transcription factor 1 (HSF1) signaling in T cell acute lymphoblastic leukemia, or … Continued

Read More